Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Feasibility of long-term patient reporting of toxicities from home via the internet during routine chemotherapy. The importance of early treatment to decrease therapy-related complications in Burkitt ...
Use of FLIM histology-based HER2-HER3 heterodimer quantification and a Bayesian latent class proportional hazards model to predict cetuximab response in the COIN and new EPOC trials. Retrospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback